{"title":"经典半乳糖血症在新生儿低γ -谷氨酰转移酶胆汁淤积症的鉴别诊断。","authors":"T Staut, D Rymen, P Vermeersch, P Witters","doi":"10.51821/88.3.14252","DOIUrl":null,"url":null,"abstract":"<p><p>Neonatal cholestasis is a diagnostic challenge that warrants extensive investigation as there can be serious sequalae such as liver failure, cirrhosis, or other extrahepatic complications. To differentiate the etiology of cholestasis, a distinction can be made between high and low gamma-glutamyltransferase (GGT) cholestasis. Low GGT cholestasis points towards progressive familial intrahepatic cholestasis type 1-2 and 4-6, bile acid synthesis disorders, tight-junction protein type 2 deficiency and some forms of hypopituitarism. Classic galactosemia is generally not included in the differential diagnosis of low GGT cholestasis. Here, we demonstrate low GGT cholestasis in 9 consecutive patients with classic galactosemia at the University Hospitals of Leuven, Belgium. All neonatal cholestasis should be managed with prompt cessation of galactose intake, but in classic galactosemia it can be lifesaving. We now add that low GGT cholestasis increases the likelihood of galactosemia. Conversely, high GGT cholestasis could point to other causes, like biliary atresia, where there may be no need to stop breastfeeding. In galactosemia, we observe a rise in GGT after initiation of a galactose-free diet, which we suggest may be partially explained by the normalization of bile acid transporter glycosylation.</p>","PeriodicalId":7322,"journal":{"name":"Acta gastro-enterologica Belgica","volume":"88 3","pages":"239-243"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Classic galactosemia in the differential diagnosis of neonatal low gammaglutamyltransferase cholestasis.\",\"authors\":\"T Staut, D Rymen, P Vermeersch, P Witters\",\"doi\":\"10.51821/88.3.14252\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Neonatal cholestasis is a diagnostic challenge that warrants extensive investigation as there can be serious sequalae such as liver failure, cirrhosis, or other extrahepatic complications. To differentiate the etiology of cholestasis, a distinction can be made between high and low gamma-glutamyltransferase (GGT) cholestasis. Low GGT cholestasis points towards progressive familial intrahepatic cholestasis type 1-2 and 4-6, bile acid synthesis disorders, tight-junction protein type 2 deficiency and some forms of hypopituitarism. Classic galactosemia is generally not included in the differential diagnosis of low GGT cholestasis. Here, we demonstrate low GGT cholestasis in 9 consecutive patients with classic galactosemia at the University Hospitals of Leuven, Belgium. All neonatal cholestasis should be managed with prompt cessation of galactose intake, but in classic galactosemia it can be lifesaving. We now add that low GGT cholestasis increases the likelihood of galactosemia. Conversely, high GGT cholestasis could point to other causes, like biliary atresia, where there may be no need to stop breastfeeding. In galactosemia, we observe a rise in GGT after initiation of a galactose-free diet, which we suggest may be partially explained by the normalization of bile acid transporter glycosylation.</p>\",\"PeriodicalId\":7322,\"journal\":{\"name\":\"Acta gastro-enterologica Belgica\",\"volume\":\"88 3\",\"pages\":\"239-243\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta gastro-enterologica Belgica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.51821/88.3.14252\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta gastro-enterologica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.51821/88.3.14252","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Classic galactosemia in the differential diagnosis of neonatal low gammaglutamyltransferase cholestasis.
Neonatal cholestasis is a diagnostic challenge that warrants extensive investigation as there can be serious sequalae such as liver failure, cirrhosis, or other extrahepatic complications. To differentiate the etiology of cholestasis, a distinction can be made between high and low gamma-glutamyltransferase (GGT) cholestasis. Low GGT cholestasis points towards progressive familial intrahepatic cholestasis type 1-2 and 4-6, bile acid synthesis disorders, tight-junction protein type 2 deficiency and some forms of hypopituitarism. Classic galactosemia is generally not included in the differential diagnosis of low GGT cholestasis. Here, we demonstrate low GGT cholestasis in 9 consecutive patients with classic galactosemia at the University Hospitals of Leuven, Belgium. All neonatal cholestasis should be managed with prompt cessation of galactose intake, but in classic galactosemia it can be lifesaving. We now add that low GGT cholestasis increases the likelihood of galactosemia. Conversely, high GGT cholestasis could point to other causes, like biliary atresia, where there may be no need to stop breastfeeding. In galactosemia, we observe a rise in GGT after initiation of a galactose-free diet, which we suggest may be partially explained by the normalization of bile acid transporter glycosylation.
期刊介绍:
The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition. Pure animal or in vitro work will not be considered for publication in the Journal. Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies). Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem. The language of the Journal is English. Papers from any country will be considered for publication. Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere. Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors. Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks. The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style. Authors have the opportunity to review such changes in the proofs.